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OBJECTIVE—Increased oxidative stress and immune dysfunction are implicated in pre-
eclampsia (PE) and may contribute to the two- to fourfold increase in PE prevalence among
women with type 1 diabetes. Prospective measures of fat-soluble vitamins in diabetic pregnancy
are therefore of interest.
RESEARCHDESIGNANDMETHODS—Maternalserumcarotenoids(a-andb-carotene,
lycopene, and lutein) and vitamins A, D, and E (a-a n dg-tocopherols) were measured at ﬁrst
(12.2 6 1.9 weeks [mean 6 SD], visit 1), second (21.6 6 1.5 weeks, visit 2), and third (31.5 6
1.7 weeks, visit 3) trimesters of pregnancy in 23 women with type 1 diabetes who subsequently
developedPE(DMPE+)and24womenwithtype1diabetes,matchedforage,diabetesduration,
HbA1c, and parity, who did not develop PE (DM PE2). Data were analyzed without and with
adjustment for baseline differences in BMI, HDL cholesterol, and prandial status.
RESULTS—In unadjusted analysis, in DM PE+ versus DM PE2, a-carotene and b-carotene
were 45 and 53% lower, respectively, at visit 3 (P , 0.05), before PE onset. In adjusted analyses,
the difference in b-carotene at visit 3 remained signiﬁcant. Most participants were vitamin D
deﬁcient (,20 ng/mL), and vitamin D levels were lower in DM PE+ versus DM PE2 throughout
the pregnancy, although this did not reach statistical signiﬁcance.
CONCLUSIONS—In pregnant women with type 1 diabetes, low serum a-a n db-carotene
were associated with subsequent development of PE, and vitamin D deﬁciency may also be
implicated.
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P
reeclampsia (PE) is deﬁned as new-
onset hypertension and proteinuria
duringpregnancy.PEisamajorcause
of maternal and infant morbidity and
mortality, and its incidence is increased
approximately fourfold by the presence
of maternal type 1 diabetes (1,2). Placental
oxidative stress is implicated in the
pathogenesis of PE (3,4), and compared
with the general population, women with
type 1 diabetes may be particularly prone
to and affected by impaired antioxidant
status. Any alterations in maternal anti-
oxidant status in pregnancy are therefore
of interest. Risk for PE has also been as-
sociated with vitamin D deﬁciency, per-
haps mediated through sequelae such as
immune dysfunction, inﬂammation, and
hypertension (5,6).
Several cross-sectional PE studies
have been performed, mostly in nondia-
betic women. Altered levels of carote-
noids (a-a n db-carotene, lycopene, and
lutein)havebeenreported(7).Mikhailetal.
(8) found decreased maternal b-carotene
levels in PE, but other studies were not
conﬁrmatory(9,10).VitaminA,orretinol,
is an essential fat-soluble vitamin with
physiologicfunctionsinmammalianrepro-
duction (11). Cross-sectional studies in
nondiabetic women with and without PE
report both lower (9) and higher (10) vita-
min A levels. Vitamin E or a-tocopherol,
which has antioxidant functions, has been
reported to be lower (8,12), higher (9,10),
or similar (13) between PE and normoten-
sive nondiabetic pregnancies.
There are some longitudinal PE stud-
ies, although none in type 1 diabetes.
Bodnaretal.(5)foundthatseverevitamin
Dd e ﬁciency [25(OH)D ,15 ng/mL] in
early pregnancy was associated with a
ﬁvefold increased risk of PE. Halhali et al.
(14) showed that serum 1, 25(OH)2D
was not altered in pregnant women who
subsequently developed PE. In a longitu-
dinal study of nondiabetic women with a
risk of high PE, Chappell et al. (15) found
no signiﬁcant differences in a-tocopherol
concentrations.
Thus, longitudinal studies are few,
and cross-sectional studies are not infor-
mative on the temporal relationship be-
tween antioxidant status and subsequent
PE.Furthermore,therearenoprospective
datarelatingserumcarotenoids,fat-soluble
vitamins, and PE in diabetes.
We report a multicenter prospec-
tive study examining differences in
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ORIGINAL ARTICLEserum carotenoids, vitamins A (retinol),
D [25(OH)D], and E (tocopherols) be-
tween women with type 1 diabetes with
and without subsequent PE. Levels were
measuredineachtrimesterofpregnancy
and before PE onset. Our study evalu-
ated the temporal association of vitamin
and antioxidant provitamin levels with PE
in type 1 diabetes.
Becauseourmajorgoalwastocompare
pregnant women with type 1 diabetes who
subsequently developed PE with those
who did not, our primary comparison is
between these two groups. We also in-
cluded healthy, normotensive, nondia-
beticpregnantwomentoobtainreference
values during pregnancy, and for illustra-
tive purposes we report some secondary
analyses using their data.
RESEARCH DESIGN AND
METHODS—This is a substudy of a
previously described prospective cohort
of 151 non-Hispanic white women with
type1diabetesand24nondiabeticsubjects
enrolled during the ﬁrst trimester of preg-
nancy and followed until delivery (16).
Clinical data and specimens were col-
lected at each trimester (visit 1: 12.2 6
1.9 weeks; visit 2: 21.6 6 1.5 weeks;
and visit 3: 31.5 6 1.7 weeks of gestation
[mean 6 SD]; no overlap) and at term
(37.6 6 2.0 weeks). Visit 3 was before
PE onset. Subjects were requested to fast
overnight, actual prandial status was
recorded, and serum and urine were ob-
tained before any exogenous insulin ad-
ministration. The study was approved by
the institutional review boards of partici-
pating centers in Norway, Australia, and
the U.S. Exclusion criteria were renal im-
pairment (including microalbuminuria),
cardiovascular disease, hypertension, or
other signiﬁcant medical problems pre-
pregnancy or at visit 1. PE was deﬁned
as new-onset hypertension (.140/90
mmHg) after 20 weeks’ gestation in a pre-
viously normotensive woman, accompa-
nied by proteinuria (.300 mg/24 h). Of
the 26 diabetic PE (DM PE+) cases in the
larger cohort (16), samples from 23 were
availableforthissubstudybecauseofsam-
ple attrition. Of 26 DM PE2 cases
matched on the basis of age, diabetes du-
ration, HbA1c, and parity, samples from
24 were available for this study (sample
attrition). For reference values, 20 of 24
pregnant, nondiabetic, non-PE women
(DM2) were also studied (3 were previ-
ously excluded as described [16]; 1 addi-
tional exclusion due to sample attrition).
Laboratory analyses
Procedures have been detailed (16). Se-
rumcarotenoids,retinol,andtocopherols
were measured by high-performance liq-
uid chromatography (HPLC) using a
modiﬁed combined version of methods
of Lee et al. (17) and Karppi et al. (18).
Table 1—Clinical proﬁles of 47 type 1 diabetic and 20 nondiabetic participants
Nondiabetic
P value: DM2 vs.
DM PE2
Diabetic
No PE (PE2)
P value: DM PE2 vs.
DM PE+ PE (PE+)
N 20 24 23
Age (years) 31.7 6 4.6 0.17 29.9 6 3.8 0.31 28.5 6 5.6
BMI (kg/m
2) 23.6 6 3.7 0.41 24.6 6 4.1 0.025 28.0 6 5.8
Alcohol use (%)
None 11*
0.55
25
0.39
18
Stopped during pregnancy 68 58 68
Smoking (%)
No 100*
0.55
88
0.69
91
Quit because of pregnancy 0 4 5
First pregnancy (%) 55 0.57 75 0.26 76
Gravida (n)1 . 7 6 1.0 0.24 1.3 6 0.7 0.99 1.3 6 0.7
Para (n)0 . 5 6 0.9 0.18 0.2 6 0.5 0.91 0.2 6 0.5
Abortus (n)0 . 2 6 0.4 0.86 0.1 6 0.3 0.91 0.1 6 0.4
Age at diabetes onset (years) — 15 6 80 . 0 6 5 1 2 6 6
Duration of diabetes (years) — 15 6 70 . 3 21 7 6 7
HbA1c (%) 5.3 6 0.3 ,0.0001 6.7 6 1.0 0.13 7.3 6 1.2
Blood pressure (mmHg)
Systolic 112 6 9 0.35 109 6 10 0.27 113 6 12
Diastolic 67 6 8 0.24 64 6 80 . 2 76 7 6 9
Microalbumin (mg/dL) 0.47 6 0.17 0.58 0.43 6 0.20 0.12 1.03 6 1.78
Total cholesterol (mg/dL) 187 6 26 0.22 176 6 34 0.54 182 6 28
HDL cholesterol (mg/dL) 81 6 22 0.63 84 6 18 0.035 74 6 14
LDL cholesterol (mg/dL) 88 6 30 0.22 77 6 28 0.10 91 6 28
Triglycerides (mg/dL) 94 6 34 0.076 75 6 31 0.17 87 6 24
Gestational age (weeks)
Visit 1 12.6 6 1.7 0.56 12.3 6 1.7 0.98 12.3 6 2.1
Visit 2 21.5 6 1.2 0.97 21.4 6 1.2 0.15 22.1 6 1.7
Visit 3 31.2 6 1.1 0.80 31.3 6 1.5 0.39 31.7 6 1.7
Term 39.2 6 1.5 0.013 38.0 6 1.4 0.036 37.2 6 1.2
Valuesaremeans6SD.Measurementsrefertovisit1unlessotherwise indicated.Pvalues,0.05aredenotedin boldface.*Forthesedata,Pvaluereferstocombined
percentage (i.e., “none” and “stopped during pregnancy,” or “no” and “quit because of pregnancy”).
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Azar and AssociatesSerum vitamin D [25(OH)D] was mea-
sured by HPLC/tandem mass spectrome-
try through Quest Diagnostics Co. (19).
Brieﬂy, 200 mL serum was deprotein-
ized with 200 mL ethanol-butylated hy-
droxytoluene containing 50 mL internal
standard cocktail, vortexed, extracted
(1,000 mL n-hexane, 60 s), dried (nitro-
gen, 10 min), and reconstituted in 200 mL
ethanol-butylated hydroxytoluene solu-
tion. Then, 50 mL was injected onto a
4.6-mm C-18 Ultrasphere ODS HPLC
column (Beckman Coulter, Inc., Danvers,
MA) and eluted (ﬂow rate 0.8 mL/min)
with an isocratic solvent (methanol,
60%; acetonitrile, 20%; and dichlorome-
thane, 20%). The HPLC system included
a 515 pump, 2996 photodiode array
detector, and a Rheodyne 7725i manual
injector(Waters,Milford,MA).Dataacqui-
sition was via Waters Empower data soft-
ware. Interassay coefﬁcient of variation
for pooled quality samples was #10%.
All assays were performed by operators
masked to sample clinical status.
Statistics
The primary analyses compared DM PE+
with DM PE2. A secondary analysis eval-
uated differences between DM PE2 and
nondiabetic non-PE control subjects
(DM2). Carotene and tocopherol levels
wereanalyzedbothwithandwithoutcor-
rection for total lipids (cholesterol + tri-
glyceride).Minimumdifferencesbetween
DM PE+ and DM PE2 (n $20/group)
could be detected with 80% power as fol-
lows: lutein: 0.4 mmol/L; a-tocopherol:
5.4 mmol/L; vitamin A: 0.18 mmol/L;
vitamin D: 3.08 mg/L. Results are re-
ported (Table 1) as means (6 SD) or, for
non-normally distributed measures (per
Shapiro-Wilks test), were transformed
logarithmically and reported as geomet-
ric means (95% CI) (all carotenoids [ex-
cept lutein], g-tocopherol, and a-o r
g-tocopherol:lipid ratios). Differences
between groups were analyzed by Student
t test for continuousmeasures and x
2 test
for categoric measures. Analyses were
performed with and without inclusion
of parameters that differed between DM
PE+ andDMPE2 (BMI,HDL cholesterol),
andprandialstatus,ascovariates.Microsoft
Excel 2007 (Microsoft Corp., Redmond,
WA) and SPSS for Windows 15.0 (SPSS
Inc., Chicago, IL) were used.
RESULTS—A ss h o w ni nT a b l e1 ,a t
baseline,thediabeticgroupswerecompa-
rableexceptforhigherBMIandlowerHDL
cholesterol in DM PE+ versus DM PE2.
Serum b-carotene was 37% lower at
visit 1 (P , 0.05), and a-a n db-carotene
were 45 and 53% lower, respectively, at
visit 3, in DM PE+ versus DM PE2 (P ,
0.05) (Fig. 1A and B), although after ad-
justment for covariates, only b-carotene
at visit 3 remained signiﬁcant. Serum lu-
tein levels were similar in DM PE+ versus
DM PE2 at all visits (Fig. 1C); lycopene
was 52% higher in DM PE+ versus
DM PE2 at visit 2 (P , 0.05) (Fig. 1D).
Serum lutein was lower at visits 1 and 2
in DM PE2 versus DM2 (Fig. 1C; P ,
0.05). Differences in lutein and lyco-
pene were not affected by the covariate
analysis.
Serum vitamin A levels did not differ
signiﬁcantly between the diabetic groups
at any visit (Fig. 2A), but were lower in
DM PE2 versus DM2 at visits 2 and 3
(Fig. 2A; P , 0.05). Consideration of co-
variates had no effect.
Figure1—Longitudinalchangesin(A)a-carotene,(B)b-carotene,(C)lutein,and(D)lycopene
during gestation. Values are geometric means for a-carotene, b-carotene, and lycopene, and
arithmetic means for lutein. Error bars show the 95% CI for the mean. Three groups of partic-
ipants are shown; white circle, dashed line: DM PE2 (n = 24); black circle, solid line: DM PE+
(n=23);whitesquare,dottedlines:DM2(nondiabeticcontrolsubjects,n=20).Exceptlutein,all
values were log-transformed before testing for signiﬁcant differences. Values signiﬁcantly (P ,
0.05) different between DM PE2 and DM PE+ groups are indicated with an asterisk (*) and
between DM PE2 and DM2 groups are indicated with a double dagger (‡). After adjustment for
covariates (BMI, HDL cholesterol, and prandial status), differences in a-carotene at visit 3 and
b-carotene at visit 1 were no longer signiﬁcant (P = 0.09 and 0.12, respectively).
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Carotenoids, vitamins, and preeclampsiaVitamin D [25(OH)D] insufﬁciency,
deﬁciency, and severe deﬁciency were
deﬁned as ,30, ,20, and ,15 ng/mL,
respectively (20,21). Mean 25(OH)D
levels did not differ signiﬁcantly between
DM PE+ and DM PE2 groups, although
there was a slight trend toward lower
levels in DM PE+ throughout pregnancy
(Fig. 2B). Also, women with type 1 diabe-
tes in general, and those who developed
PE in particular, were more likely to be
vitamin D deﬁcient or severely deﬁcient
than the nondiabetic group, and the rela-
tive risk of PE associated with vitamin D
deﬁciency was increased, although not
signiﬁc a n t l ya ta n yv i s i t( T a b l e2 ) .O f
r e l e v a n c et ov i t a m i nD ,t h e r ew e r en o
differences between groups in the seasons
of sample collection (data not shown), and
all enrolled participants were Caucasian.
Unadjusted a-tocopherol levels were
;18%higherinDMPE+versusDMPE2
at visit 2 (Fig. 2C; P , 0.05), whereas
g-tocopherol was similar in all groups
at all visits (Fig. 2D). Mean serum
a-tocopherol was lower in DM PE2 ver-
susDM2onlyatvisit2(Fig.2C;P,0.05).
Nodifferenceswerenotedforg-tocopherol
at any visit (Fig. 2D). Covariate analysis
did not affect signiﬁcance.
Because carotenes and tocopherols
circulate primarily within lipoproteins,
levels were adjusted for serum total lipids
(Fig. 3). Lipid-adjusted carotenes were
lower in DM PE+ than DM PE2 at visit
1( b-carotene only) and visit 3 (both car-
otenes) (Fig. 3A and B; P , 0.05). Again,
afterinclusionofcovariates,onlyb-carotene
at visit 3 remained signiﬁcant. Adjusted
lycopene and lutein levels showed no dif-
ferences between groups at any visit (data
not shown). By comparing DM PE2 with
DM2, adjusted a-a n db-carotenoids
were not signiﬁcantly different, but they
tended to decline with gestational age
in both groups. Lipid-adjusted a-a n d
g-tocopherols did not differ between DM
PE+ and DM PE2, or between DM2 and
DM PE2,a l t h o u g ha-tocopherol trended
downward in all groups during preg-
nancy (Fig. 3C). Differences in tocopherol:
lipid ratios were not affected by covariate
analysis.
CONCLUSIONS—In a prospective
study of pregnant women with type 1
diabetes, we demonstrated lower serum
carotenoids, especially b-carotene, in af-
fected versus unaffected women before
PE onset. We also observed a high preva-
lence ofvitaminDinsufﬁciency, most fre-
quently in women who developed PE.
Relative to early pregnancy, there was
also a downward trend in lipid-adjusted
carotenoids and tocopherols in the third
trimester, perhaps representing antioxi-
dant reserve depletion. This decline oc-
curred because total cholesterol and
triglycerides increased by 1.5- and two-
fold, respectively, between visits 1 and 3
(not shown) in all groups. We have pre-
viously shown that pregnant women with
type 1 diabetes are already “primed” for
PE by having elevated levels of endoglin
(16), and in this setting, antioxidant de-
pletion may trigger PE.
We identiﬁed signiﬁcantly lower se-
rum b-carotene, and by some analyses,
lower a-carotene, in pregnant women
with type 1 diabetes who subsequently
developed PE versus those who did
not. Our longitudinal data, particularly
between-groupdifferencesinserumcar-
o t e n o i d s( D MP E +v s .D MP E 2)i nt h e
third trimester, concur with existing
cross-sectional studies, performed later
in pregnancy in nondiabetic women,
that show lower circulating carotenoids
in PE (8,10). b-Carotene also possesses
pro-vitamin A activity (22), and we pos-
tulate that the low b-carotene in the
third trimester could be explained by in-
creased endogenous antioxidant consump-
tion due to elevated oxidative stress or
Figure 2—Longitudinal changes in (A) retinol, (B) vitamin D (cholecalciferol), (C) a-tocopherol,
and (D) g-tocopherol (log transformed) during gestation. Values are arithmetic means for retinol,
cholecalciferol, and a-tocopherol, and geometric means (95% CI) for g-tocopherol. Group and sta-
tistical symbols are as in Fig. 1. Adjustment for covariates had no effect on signiﬁcance. Statistically
signiﬁcant differences between visits were seen for (C) a-tocopherol in DM PE+ between gestational
age 12 and 22 weeks, and in DM PE2 between gestational age 22 and 32 weeks (P , 0.05).
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Azar and Associatesincreased conversion to vitamin A to
compensate for low vitamin A levels. In
our study, low vitamin A levels in women
with type 1 diabetes in the ﬁrst trimester
are comparable to those previously re-
ported (9,10) and to levels in U.S. adult
women (23). Thus, although not statisti-
cally signiﬁcant, decreasing vitamin A
levels between the second and third tri-
mesters in women with type 1 diabetes
could promote PE.
Vitamin D deﬁciency, an increas-
ingly prevalent condition in women of
childbearing age (20), has been associ-
ated with PE in a large prospective study
(5). We found that the majority of our
participants, regardless of geographic
location (which included sunny regions
such as Oklahoma, South Carolina, and
Australia), were vitamin D deﬁcient.
Levels did not differ between sites. We
lack information on dietary intake or
ultraviolet light exposure. The women
withtype1diabetesasawholehadlower
levels than our nondiabetic reference
group (data not shown). The reason is
unclear. Occult celiac disease, which
may cause vitamin D malabsorption, is
prevalent (5–10%) in type 1 diabetes
(24) and could be contributory.
Links between vitamin D deﬁciency
and PE are unclear. Hyppönen (6) pro-
posed an immune hypothesis, whereby
local disruption of vitamin D status pro-
m o t e sl o s so fm a t e r n a l –fetal immune
tolerance and immune maladaptation.
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Figure 3—Longitudinal changes in ratios (A) a-carotene: total lipids, (B) b-carotene: total
lipids, (C) a-tocopherol: total lipids, and (D) g-tocopherol: total lipids, during gestation. Values
aregeometricmeans(95%CI).Ratiosareexpressedasserumtocopherolandcarotenoidmolarity
(mmol/L) to total lipid mass (serum total cholesterol and triglycerides) (mg/dL). Group and
statistical symbols are as in Fig. 1. After adjustment for covariates (BMI, HDL cholesterol, and
prandial status), differences in a-carotene at visit 3 and b-carotene at visit 1 were no longer
signiﬁcant (P = 0.08 and 0.07, respectively).
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Carotenoids, vitamins, and preeclampsiaAlthoughthisisintriguing,ithas yetto be
established as a cause for PE in humans.
Another possibility is diminished placen-
tal 1a-hydroxylase activity, which occurs
inPE(25)andlowerslocalandcirculating
1,25(OH)2D.
In agreement with Williams et al. (10),
our study does not support a relationship
between serum a-a n dg-tocopherols
and PE, although the decline in adjusted
a-tocopherol levels throughout the preg-
nancy might have a permissive effect in
women already predisposed. The mean
ﬁrst trimester serum a-tocopherol values
(25–30mmol/L)inthewomenwithtype1
diabetes in our study were comparable to
normalvaluesinU.S.adultsandabovethe
threshold indicating vitamin E deﬁciency
(,11.6 mmol/L) (23).
Our study has several limitations.
The ﬁndings merit conﬁrmation in larger
prospective studies involving diabetic
and nondiabetic women. Furthermore,
confounding due to certain group dif-
ferences in this small cohort, although
nonsigniﬁcant, cannot be excluded. More
data regarding maternal diet, vitamin
supplementuse,andultravioletexposure
would have been helpful to dissect cause
and effect.Measures of other antioxidant
vitamins and enzymes would be of in-
terest. Fasting overnight is challenging
for pregnant women with type 1 diabe-
tes,andateachvisit,asimilarproportion
from each diabetic group (range 2–6o f
23 or 24) attended nonfasting. However,
our conclusions were not substantially
affected by statistical adjustment for
prandial status (as presented) or exclusion
of nonfasting visits (data not shown).
We believe this is the ﬁrst longitudi-
nal study of the relationship between PE
in pregnant women with type 1 diabetes
and antecedent serum levels of carote-
noidsandvitaminsA,D,andE.Wefound
that women with type 1 diabetes who
developed PE had lower antecedent se-
rum a-a n db-carotene concentrations
than those who did not. Vitamin D insuf-
ﬁciency affected most women with type 1
diabetes, and levels tended to be lower in
those who developed PE. Lipid-adjusted
levels of many of the fat-soluble antioxi-
dants declined during pregnancy. Our
study sample, although small, repre-
sented women with type 1 diabetes from
different geographic locations. Further
studies are needed to deﬁne whether op-
timizing fat-soluble antioxidant and vita-
min status throughout pregnancy can
reduce the high incidence of PE in those
with type 1 diabetes.
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